McConnell Brain Imaging Centre, Montreal Neurological Institute, Montreal, Canada
Johannes Levin
Department of Neurology, Ludwig-Maximilians-Universität München, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
Hiroshi Mori
Department of Clinical Neuroscience, Osaka City University Medical School, Osaka, Japan
Jae Hong Lee
Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
Martin Rhys Farlow
Department of Neurology, Indiana University, Bloomington, United States
Peter Schofield
Neuroscience Research Australia, Sydney, Australia; School of Medical Sciences, UNSW Sydney, Sydney, Australia
Jasmeer P Chhatwal
Harvard Medical School, Massachusetts General Hospital, Boston, United States
Colin L Masters
The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Australia
Tammie Benzinger
Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, United States; Department of Neurology, Washington University School of Medicine, St. Louis, United States
John Morris
Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, United States; Department of Neurology, Washington University School of Medicine, St. Louis, United States
Randall Bateman
Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, United States; Department of Neurology, Washington University School of Medicine, St. Louis, United States
John CS Breitner
Department of Psychiatry, Faculty of Medicine, McGill University, Montreal, Canada; Douglas Mental Health University Institute, Montreal, Canada
Judes Poirier
Department of Psychiatry, Faculty of Medicine, McGill University, Montreal, Canada; Douglas Mental Health University Institute, Montreal, Canada
Julie Gonneaud
Douglas Mental Health University Institute, Montreal, Canada; Normandie Univ, UNICAEN, INSERM, U1237, Institut Blood and Brain @ Caen-Normandie, Cyceron, Caen, France
Maxime Descoteaux
Sherbrooke Connectivity Imaging Laboratory (SCIL), Université de Sherbrooke, Sherbrooke, Canada
Sylvia Villeneuve
Department of Psychiatry, Faculty of Medicine, McGill University, Montreal, Canada; Douglas Mental Health University Institute, Montreal, Canada; McConnell Brain Imaging Centre, Montreal Neurological Institute, Montreal, Canada
Beta-amyloid (Aβ) and tau proteins, the pathological hallmarks of Alzheimer’s disease (AD), are believed to spread through connected regions of the brain. Combining diffusion imaging and positron emission tomography, we investigated associations between white matter microstructure specifically in bundles connecting regions where Aβ or tau accumulates and pathology. We focused on free-water-corrected diffusion measures in the anterior cingulum, posterior cingulum, and uncinate fasciculus in cognitively normal older adults at risk of sporadic AD and presymptomatic mutation carriers of autosomal dominant AD. In Aβ-positive or tau-positive groups, lower tissue fractional anisotropy and higher mean diffusivity related to greater Aβ and tau burden in both cohorts. Associations were found in the posterior cingulum and uncinate fasciculus in preclinical sporadic AD, and in the anterior and posterior cingulum in presymptomatic mutation carriers. These results suggest that microstructural alterations accompany pathological accumulation as early as the preclinical stage of both sporadic and autosomal dominant AD.